Circulation Research. 2008;103:223-225
doi: 10.1161/CIRCRESAHA.108.181636
(Circulation Research. 2008;103:223.)
© 2008 American Heart Association, Inc.
Calsequestrin Mutations and Sudden Death
A Case of Too Little Sarcoplasmic Reticulum Calcium Buffering?
Luigi A. Venetucci,
David A. Eisner
From the Unit of Cardiac Physiology, University of Manchester, UK.
Correspondence to D. A. Eisner, Unit of Cardiac Physiology, University of Manchester, 3.18 Core Technology Facility, 46 Grafton St, Manchester M13 9NT, United Kingdom. E-mail eisner@man.ac.uk
See related article, pages 298–306
An extract of the first 250 words of the full text is provided, because this article has no abstract.
|
 |
Introduction
|
|---|
In cardiac muscle, calcium plays a crucial role in excitation–contraction
coupling, but it is also implicated in arrhythmogenesis. Calcium
is released from the sarcoplasmic reticulum (SR), resulting
in the systolic Ca transient. This release occurs through a
specialized channel, the ryanodine receptor (RyR). The RyR is
formed by the assembly of 4 identical subunits and binds several
accessory proteins that are involved in the control of its function.
Channel opening is influenced by Ca levels on both the luminal
and cytosolic side and the amount of Ca released depends steeply
1 on SR Ca content.
 |
Diastolic Calcium Release and Arrhythmias
|
|---|
In various conditions, the SR can release Ca independently from
an action potential. This diastolic release propagates through
the cell as a wave of calcium-induced calcium release. Some
of the calcium is pumped out of the cell by the electrogenic
Na–Ca exchange, resulting in delayed afterdepolarizations
(DADs) and triggered arrhythmias (reviewed elsewhere
2). Diastolic
Ca release occurs when the SR Ca concentration reaches a critical,
threshold level.
3 Recent studies have suggested that DADs and
arrhythmias can be produced not only as a consequence of elevated
SR Ca content but also if the properties of Ca release from
the SR are altered.
 |
Cathecholiminergic Polymorphic Ventricular Tachycardia
|
|---|
Catecholaminergic polymorphic ventricular tachycardia (CPVT)
is a familial arrhythmogenic disorder characterized by the onset
of ventricular tachycardia (VT) during stress. Two forms have
been described, an autosomal dominant (CPVT-1) resulting from
mutations of RyR
4,5 and an autosomal recessive (CPVT-2) resulting
from mutations of calsequestrin (CSQ).
6 Both animal
7 and human
8 studies have demonstrated that CPVT-1 arrhythmias
. . . [Full Text of this Article]
Related Article:
-
Unexpected Structural and Functional Consequences of the R33Q Homozygous Mutation in Cardiac Calsequestrin: A Complex Arrhythmogenic Cascade in a Knock In Mouse Model
- Nicoletta Rizzi, Nian Liu, Carlo Napolitano, Alessandra Nori, Federica Turcato, Barbara Colombi, Silvio Bicciato, Diego Arcelli, Alessandro Spedito, Mario Scelsi, Laura Villani, Giovanni Esposito, Simona Boncompagni, Feliciano Protasi, Pompeo Volpe, and Silvia G. Priori
Circ. Res. 2008 103: 298-306.
[Abstract]
[Full Text]
[PDF]